ArticleJACC. Case reports2026
Robotic-Assisted Aortic Valve Replacement in a Hybrid Approach to Concomitant Aortic Valve and Coronary Disease.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Optimization of Minimally Invasive Aortic Valve Replacement.JACC. Case reports · 2026Article
- Safety, Optimal Valve Therapy and Then Approach: We All Agree.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobotic-assisted aortic valve replacement (RAVR) has emerged as a novel minimally invasive approach to surgically manage aortic valve disease. CASE SUMMARY: A 74-year-old man presented with several months of worsening dyspnea and chest pain on exertion. Preoperative work-up identified severe aortic stenosis along with coronary artery disease. Despite being at low operative risk, the patient had a small aortic root, coronary disease not amenable to surgical revascularization, and wanted to avoid sternotomy. The decision was made to perform RAVR with percutaneous coronary intervention in a hybrid approach to manage his concomitant pathologies. DISCUSSION: We demonstrate the safety and feasibility of performing RAVR using a sutureless aortic valve prosthesis to optimize hemodynamics in a patient with a small aortic root. We also describe the combination of RAVR and percutaneous coronary intervention as part of a hybrid treatment paradigm to manage concomitant aortic stenosis and coronary artery disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.